Our articles keep health professionals up-to-date with the happenings throughout the industry.

Clinical Articles

HPS Pharmacies prides itself on providing innovative and informative support to assist in the diverse range of issues health professionals face on a day-to-day basis, and to facilitate the distribution of this information for a variety of sectors within the healthcare industry.

HPS’ clinical articles are written by HPS Pharmacies’ experienced and knowledgeable staff and are peer-reviewed by specialist leaders in their field to ensure the accuracy of the information provided. The resourceful and diverse range of articles play an integral role in keeping all health professionals up-to-date with the happenings throughout the industry on a regular basis.

Potentially Inappropriate Medicines in the Australian Setting

A list of potentially inappropriate medicines (PIMs) specific to the Australian setting has recently been published. Potentially inappropriate medicines can be defined as medications with risks that may outweigh their benefits in older adults….

Read more

Intranasal Corticosteroids in Allergic Rhinitis

Rhinitis is an inflammation of the lining of the nose, causing congestion, rhinorrhoea, sneezing and itching. It is classified as allergic (hay fever) or non-allergic (including drug-induced, irritant, occupational) rhinitis. Allergic rhinitis is a…

Read more

Updated COVID-19 Vaccine Recommendations

While COVID-19 may no longer be considered a public health emergency, it continues to have a significant impact on health services and the community. Residential aged care homes (RACH) continue to experience outbreaks. As…

Read more

Medication-Overuse Headache

Medication-overuse headache is a neurologic disorder that can cause significant disability and suffering. This condition typically only occurs in patients with migraine or tension headaches and is associated with overuse of medications for the…

Read more

Data and Decisions for the Three Different CDK4/6 Inhibitors

Hormone receptor-positive and HER2 receptor-negative (HR+/HER2-) breast cancer can be treated with CDK4/6 inhibitors. When cyclin-dependent kinase (CDK) cellular biology becomes dysregulated, cell proliferation occurs, and this has led to the discovery of three…

Read more

Changes Affecting Submissions for Unapproved Therapeutic Goods

The Therapeutic Goods Administration (TGA) has announced plans to transition Special Access Scheme (SAS) and Authorised Prescriber (AP) submissions to a fully digital model. Once this is implemented, paper-based submissions (including faxed and emailed…

Read more
Load More

October 2023

August 2023

May 2023

Sepsis (May. 26 2023)

Patient Self-Management (May. 12 2023)

February 2023

Wernicke-Korsakoff Syndrome (Feb. 17 2023)

Gestational Diabetes (Feb. 03 2023)

September 2022

August 2022

Monkeypox in Australia (Aug. 19 2022)

Anticholinergic Burden (Aug. 05 2022)

March 2022

February 2022

January 2022

November 2021

August 2021

July 2021

May 2021

April 2021

February 2021

January 2021

COVID-19 Vaccines (Jan. 28 2021)

Updates to the Poisons Standard (Jan. 15 2021)

November 2020

Antimicrobial Resistance (Nov. 20 2020)

Vaccines and Cold Chain (Nov. 06 2020)

October 2020

September 2020

August 2020

February 2020

Xerostomia (Feb. 27 2020)

Monoclonal Antibodies for Migraine (Feb. 13 2020)

January 2020

Changes to Neural Connector Devices (Jan. 30 2020)

Venetoclax (Jan. 16 2020)

Biosimilars in Oncology (Jan. 03 2020)

October 2019

Lamotrigine Dose Escalation (Oct. 25 2019)

Wilson Disease (Oct. 11 2019)

September 2019

August 2019

July 2019

February 2019

January 2019

Biofilms (Jan. 18 2019)

Medications and Sun Exposure (Jan. 04 2019)